Lovaza's Effect on Clopidogrel in a Neuro Population

Recruiting

Phase 0 Results N/A

Summary of Purpose

In patients who have suffered an ischemic stroke or TIA (mini-stroke), as well as in patients who are candidates for neuroendovascular stenting, it is standard of care to treat these patients with antiplatelet therapy, or "blood-thinners", the most common of which is clopidogrel (Plavix) with or without the addition of aspirin. A relatively common problem encountered with these patients is non-responsiveness to...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 February 2012.

1 Sep 2011 31 Jan 2012 1 Sep 2013 1 Sep 2013 1 Feb 2012 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Pharmacodynamics Study
  • Intervention: Parallel Assignment

Contacts